🕵️ Immunitybio, Inc. ($IBRX)
SEC insider & ownership activity, last 12 months · CIK 1326110 · every row links its SEC filing
Over the last 12 months insiders sold $8.4M with no open-market buying against it. Barry J. Simon sold $4.1M through a 10b5-1 trading plan in 7 lots (Jan–Jun). 2 planned sales are pending, the largest $834K (Christobel Selecky). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $8.4M (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Barry J. Simon | 0 | – | 7 | $4.1M | Jun 24, 2026 |
| Selecky Christobel | 0 | – | 6 | $3.0M | Jul 1, 2026 |
| Cheryl L Cohen | 0 | – | 1 | $1.2M | Jul 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Patrick Soon-Shiong | 66.3% | 13D | Feb 23, 2026 | filing ↗ | |
| NANT Capital, LLC | 30.3% | 13D | Feb 23, 2026 | filing ↗ | |
| Cambridge Equities, LP | 25.5% | 13D | Feb 23, 2026 | filing ↗ | |
| MP 13 Ventures, LLC | 25.5% | 13D | Feb 23, 2026 | filing ↗ | |
| California Capital Equity, LLC | 10.4% | 13D | Feb 23, 2026 | filing ↗ | |
| Nantworks, LLC | 9.6% | 13D | Feb 23, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Cheryl L Cohen | $1.2M | Jul 2, 2026 | filing ↗ |
| Christobel Selecky | $1.4M | Jul 1, 2026 | filing ↗ |
| Christobel Selecky | $9K | Jun 30, 2026 | filing ↗ |
| Christobel Selecky | $834K | Jun 29, 2026 | filing ↗ |
| Barry J. Simon | $2.9M | Jun 4, 2026 | filing ↗ |
| Christobel Selecky | $218K | Feb 23, 2026 | filing ↗ |
| Christobel Selecky | $138K | Jan 20, 2026 | filing ↗ |
| Barry J. Simon | $5.9M | Jan 20, 2026 | filing ↗ |
| Christobel Selecky | $198K | Jan 16, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Material agreement (1.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Apr 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 30, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Earnings (2.02) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Other events (8.01) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 23, 2026 | filing ↗ |
| Earnings (2.02) | Jan 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing ↗ |
| Other events (8.01) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 12, 2025 | filing ↗ |